Edmonston, D., Mulder, H., Lydon, E., Chiswell, K., Lampron, Z., Shay, C., Marsolo, K., Shah, R. C., Jones, W. S., Gordon, H., Hwang, W., Ayoub, I., Ford, D., Chamberlain, A., Rao, A., Fonseca, V., Chang, A., Ahmad, F., Hung, A., Hunt, K., … Pagidipati, N. Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes. Journal of the American College of Cardiology, 84(8), 696–708. https://doi.org/10.1016/j.jacc.2024.06.016